A new drug based on decades of research at the University of Cambridge has today been approved by the National Institute for Health and Care Excellence (NICE) for use in people with relapsing-remitting multiple sclerosis. Lemtrada, manufactured by pharmaceutical company Genzyme, began life as Campath-1H, a drug developed out of research by Professor Herman Waldmann […]
Functional nerve cells from skin cells
A new method of generating mature nerve cells from skin cells could greatly enhance understanding of neurodegenerative diseases, and could accelerate the development of new drugs and stem cell-based regenerative medicine. By studying how nerves form in developing tadpoles, a research team at the Department of Oncology – led by Dr Anna Philpott – was […]
Lifestyles changes are more effective for combating diabetes than focusing on genetic risk
Recent research from the MRC Epidemiology Unit has found that public health strategies aimed at tackling obesity through lifestyle interventions are more appropriate for preventing type 2 diabetes than targeted changes based on an individual’s genetic risk. Lifestyle interventions can reduce the risk of developing diabetes in high-risk individuals by 50%; however, whether there is […]
The Biomedical Campus’ Cricket team goes to the top of the league table
Amongst the plethora of Scientific and Clinical collaborations at the Addenbrooke’s site, one such joint effort on the sports field has been taking place. The Interdepartmental League and cup competitions have been part of University Cricket for decades (possibly longer!) This year sees a team from Mol Bio (MRCLMB, MRCMBU, CBR and others) join forces […]
